Aster Medipharm Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Voglicose GM 2mg/500mg/0.3mg Tablet is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels.
Tablet
Voglicose GM 2mg/500mg/0.3mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. The medicine should be taken with food to avoid an upset stomach and can cause hypoglycemia when used with other antidiabetic medicines, alcohol, or if a meal is delayed or missed. Regular liver function checks are recommended, and any symptoms such as abdominal pain, loss of appetite, or jaundice should be reported to a doctor.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Voglicose GM 2mg/500mg/0.3mg Tablet is to be taken on an empty stomach.
Voglicose GM 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Voglicose GM 2mg/500mg/0.3mg Tablet is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medication is prescribed for the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken alongside a balanced diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin decreases glucose production by the liver and enhances insulin sensitivity. Voglibose acts as an alpha-glucosidase inhibitor, lowering postprandial (after meals) glucose levels.
Common side effects associated with Voglicose GM 2mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
It is essential to refrain from using this medication in patients with known allergies to any of the components or excipients. Additionally, avoid its usage in individuals with moderate to severe kidney disease and inflammatory bowel diseases such as ulcerative colitis or Crohn's disease. The use of Voglicose GM 2mg/500mg/0.3mg Tablet is also not recommended if there is a history of metabolic acidosis, including diabetic ketoacidosis.
No, combining alcohol with Voglicose GM 2mg/500mg/0.3mg Tablet is not advised. It can lower your blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, the use of Voglicose GM 2mg/500mg/0.3mg Tablet can lead to hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feelings of anxiety or shakiness. It is more likely to occur if you miss meals or snacks, drink alcohol, exercise excessively, or take other antidiabetic medications simultaneously.
Store this medication in its original packaging, tightly closed. Follow the storage instructions provided on the package or label. Dispose of unused medication. Ensure that it is not accessible to pets, children, and other individuals.